Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 145

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 145
---
reements may be sold by us to Keystone at our discretion from time to time from the applicable Keystone Commencement Date until the earliest to occur of (i) the 36-month anniversary of the effective date of the applicable Registration Statement, (ii) the date on which Keystone has purchased the Keystone Commitment Amount pursuant to the Keystone Purchase Agreements, (iii) the date on which our Common Stock fails to be listed or quoted on Nasdaq or any successor Eligible Market (as defined in the Keystone Purchase Agreements), and (iv) the date on which, pursuant to or within the meaning of any bankruptcy law, a custodian is appointed for us or for all or substantially all of our property, or we make a general assignment for the benefit of our creditors (each, a “Termination Event”). Although the Keystone Purchase Agreements provide that we may sell up to an aggregate of $25 million of our shares of our Common Stock to Keystone, we have only registered an aggregate of 742,215,260 shares of Common Stock for resale under the Registration Statements, including the registration statement of which this prospectus forms a part and the Prior Registration Statements. If it becomes necessary for us to issue and sell to Keystone under the Keystone Purchase Agreements more shares than are being registered for resale under the Registration Statements in order to receive aggregate gross proceeds equal to $25 million under the Keystone Purchase Agreements, we must first file with the SEC one or more additional registration statements to register under the Securities Act the resale by Keystone of any such additional shares of our Common Stock we wish to sell from time to time under the Keystone Purchase Agreements, which the SEC must declare effective, in each case, before we may elect to sell any additional shares of our Common Stock to Keystone under the Keystone Purchase Agreements. Purchases of Shares of our Common Stock Under the Keystone Purchase Agreements During the term described above, on any business day on which the closing sale price of the Common Stock is equal to or greater than $20.00 (the “Fixed Purchase Date”), we will have the right, but not the obligation, from time to time at our sole discretion, to direct Keystone, by delivery of an irrevocable written notice (a “Fixed Purchase Notice”), to purchase a number of shares of our Common Stock up to the lesser of 2,000 shares of Common Stock or $10,000,000 (the “Fixed Purchase Maximum Amount”) at a purchase price equal to the lesser of 90% of (i) the daily VW